510(k) Report

510(k) · Cleared

Cleared

BIOFIRE SPOTFIRE Respiratory/Sore Throat Panel Mini

K243544510(k) Dual TrackCleared Aug 14, 2025272-day reviewClass II21 CFR 866.3981

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biofire Diagnostics, LLC · QOF Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

Cleared on Aug 14, 2025 as substantially equivalent to K241194 (Biofire Diagnostics, LLC, 2024) after a 272-day review. Its family tree reaches back 4 generations to 2021.

Decided
Aug 14, 2025
Review
272 days
Class
Class II
Product code
QOF
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to DEN200031 (2021). No later device cites it as a predicate yet.

  1. Root · 4 generations backDEN200031 BioFire Respiratory Panel 2.1 (RP2.1)Biofire Diagnostics, LLC · 2021
  2. 3 generations backK213954 BIOFIRE SPOTFIRE Respiratory (R) PanelBiofire Diagnostics · 2023
  3. 2 generations backK232954 BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) PanelBiofire Diagnostics, LLC · 2024 · Recalled
  4. 1 generation backK241194 BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel MiniBiofire Diagnostics, LLC · 2024
  5. This deviceK243544 BIOFIRE SPOTFIRE Respiratory/Sore Throat Panel MiniBiofire Diagnostics, LLC · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4DEN200031BioFire Respiratory Panel 2.1 (RP2.1)Biofire Diagnostics, LLC2021—
−3K213954BIOFIRE SPOTFIRE Respiratory (R) PanelBiofire Diagnostics2023—
−2K232954BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) PanelBiofire Diagnostics, LLC20241
−1K241194BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel MiniBiofire Diagnostics, LLC2024—
0 (this device)K243544BIOFIRE SPOTFIRE Respiratory/Sore Throat Panel MiniBiofire Diagnostics, LLC2025—
FIG. 1 — Lineage of K243544, 2021–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QOF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QOF device

  1. #1 K241240 Panther Fusion SARS-CoV-2/Flu A/B/RSV Assayscore 17.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K241194BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel Mini
Summary page 6
…866.3981 Classification Name: Multi-Target Respiratory Specimen Nucleic Acid Test Including SARS-CoV-2 And Other Microbial Agents Product Code: QOF Predicate Device: K241194 – BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini…
Biofire Diagnostics, LLC2024—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 4 years and passes through 2 companies; a new generation was cleared every 1.2 years on median.
  • 1 of the 4 ancestors has a recall of any class.

How does its category compare?

All QOF devices

QOF Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · QOF

13in 2025

2021: 12023: 72024: 92025: 132026 (partial year): 8
2007high 13 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QOF

178in 2025

2023: 238 days median2024: 147 days median2025: 178 days median2026 (partial year): 128 days median
2007high 238 (2023) · low 147 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QOF

2so far in 2026, the most since 2007

2023: 12024: 12025: 12026 (partial year): 2
2007high 2 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · QOF

10in 2025

2023: 62024: 302025: 10
2007high 30 (2024) · low 0 (2007)2025

MAUDE reports naming product code QOF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20211—00
20220—00
2023723816
20249147130
202513178110
202681282—

What is it indicated for?

The BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel Mini is an automated multiplexed polymerase chain reaction (PCR) test intended for use with the BIOFIRE SPOTFIRE System for the simultaneous, qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swab (NPS) or anterior nasal swab (ANS) specimens obtained from individuals with signs and symptoms of respiratory tract infection, including…

Read the full statement (321 words)

The BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel Mini is an automated multiplexed polymerase chain

reaction (PCR) test intended for use with the BIOFIRE SPOTFIRE System for the simultaneous, qualitative detection and

identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swab (NPS) or anterior nasal

swab (ANS) specimens obtained from individuals with signs and symptoms of respiratory tract infection, including

COVID-19; (Respiratory menu) or in throat swab (TS) specimens from individuals with signs and symptoms of

pharyngitis; (Sore Throat menu).

The following analytes are identified and differentiated using the BIOFIRE SPOTFIRE R/ST Panel Mini:

Respiratory Menu

Viruses

Coronavirus SARS-CoV-2

Human rhinovirus

Influenza A virus

Influenza B virus

Respiratory syncytial virus

Sore Throat Menu

Viruses

Human rhinovirus

Influenza A virus

Influenza B virus

Respiratory syncytial virus

Bacteria

Streptococcus pyogenes (group A Strep)

Nucleic acids from the viral and bacterial organisms identified by this test are generally detectable in NPS/ANS/TS

specimens during the acute phase of infection. The detection and identification of specific viral and bacterial nucleic acids

from individuals exhibiting signs and symptoms of respiratory infection and/or pharyngitis is indicative of the presence of

the identified microorganism and aids in diagnosis if used in conjunction with other clinical and epidemiological

information, and laboratory findings. The results of this test should not be used as the sole basis for diagnosis, treatment,

or other patient management decisions.

Negative results in the setting of a respiratory illness and/or pharyngitis may be due to infection with pathogens that are

not detected by this test, or a respiratory tract infection that may not be detected by an NPS, ANS, or TS specimen.

Positive results do not rule out co-infection with other organisms. The agent(s) detected by the BIOFIRE SPOTFIRE

R/ST Panel Mini may not be the definite cause of disease.

Additional laboratory testing (e.g., bacterial and viral culture, immunofluorescence, and radiography) may be necessary

when evaluating a patient with possible respiratory tract infection and/or pharyngitis.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K243544: BIOFIRE SPOTFIRE Respiratory/Sore Throat Panel Mini.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K243544

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026